Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) affects health-related quality of life (HRQoL); few treatments have demonstrated clinically meaningful HRQoL benefit. KEYNOTE-040 evaluated pembrolizumab vs standard of care (SOC) in patients with recurrent and/or metastatic HNSCC whose disea...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Natl Cancer Inst
Главные авторы: Harrington, Kevin J, Soulières, Denis, Le Tourneau, Christophe, Dinis, Jose, Licitra, Lisa F, Ahn, Myung-Ju, Soria, Ainara, Machiels, Jean-Pascal H, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Ellison, Misoo C, Cheng, Jonathan D, Chirovsky, Diana Romana, Swaby, Ramona F, Cohen, Ezra E W
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850527/
https://ncbi.nlm.nih.gov/pubmed/32407532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa063
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы